SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-008145
Filing Date
2021-02-10
Accepted
2021-02-10 17:37:43
Documents
2
Period of Report
2021-02-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3304
2 POWER OF ATTORNEY ea134944ex24_geminitherap.htm EX-24 7039
  Complete submission text file 0001213900-21-008145.txt   11794
Mailing Address C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Business Address
Ong Tuyen (Reporting) CIK: 0001673178 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39438 | Film No.: 21615319

Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Issuer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations